C161H271N35O2S4 — CID 158142560
N-benzyl-2-methylpropan-2-amine;tris(N-tert-butylaniline);N-tert-butyl-1-methylimidazol-2-amine;N-tert-butyl-1-methylimidazol-4-amine;N-tert-butyl-1,3-oxazol-2-amine;N-tert-butyl-1,3-oxazol-4-amine;N-tert-butylpyrazin-2-amine;N-tert-butylpyridin-2-amine;N-tert-butylpyridin-4-amine;N-tert-butylpyrimidin-2-amine;N-tert-butyl-1,3-thiazol-2-amine;N-tert-butyl-1,3-thiazol-4-amine;ethane;methane;2-methyl-N-(pyridin-2-ylmethyl)propan-2-amine;2-methyl-N-(pyridin-4-ylmethyl)propan-2-amine;2-methyl-N-(1,3-thiazol-4-ylmethyl)propan-2-amine;2-methyl-N-(thiophen-2-ylmethyl)propan-2-amine (PubChem CID 158142560) has the molecular formula C161H271N35O2S4 and a molecular weight of 2857.45 g/mol. Its IUPAC name is N-benzyl-2-methylpropan-2-amine;tris(N-tert-butylaniline);N-tert-butyl-1-methylimidazol-2-amine;N-tert-butyl-1-methylimidazol-4-amine;N-tert-butyl-1,3-oxazol-2-amine;N-tert-butyl-1,3-oxazol-4-amine;N-tert-butylpyrazin-2-amine;N-tert-butylpyridin-2-amine;N-tert-butylpyridin-4-amine;N-tert-butylpyrimidin-2-amine;N-tert-butyl-1,3-thiazol-2-amine;N-tert-butyl-1,3-thiazol-4-amine;ethane;methane;2-methyl-N-(pyridin-2-ylmethyl)propan-2-amine;2-methyl-N-(pyridin-4-ylmethyl)propan-2-amine;2-methyl-N-(1,3-thiazol-4-ylmethyl)propan-2-amine;2-methyl-N-(thiophen-2-ylmethyl)propan-2-amine.
| Compound Name | N-benzyl-2-methylpropan-2-amine;tris(N-tert-butylaniline);N-tert-butyl-1-methylimidazol-2-amine;N-tert-butyl-1-methylimidazol-4-amine;N-tert-butyl-1,3-oxazol-2-amine;N-tert-butyl-1,3-oxazol-4-amine;N-tert-butylpyrazin-2-amine;N-tert-butylpyridin-2-amine;N-tert-butylpyridin-4-amine;N-tert-butylpyrimidin-2-amine;N-tert-butyl-1,3-thiazol-2-amine;N-tert-butyl-1,3-thiazol-4-amine;ethane;methane;2-methyl-N-(pyridin-2-ylmethyl)propan-2-amine;2-methyl-N-(pyridin-4-ylmethyl)propan-2-amine;2-methyl-N-(1,3-thiazol-4-ylmethyl)propan-2-amine;2-methyl-N-(thiophen-2-ylmethyl)propan-2-amine |
|---|---|
| PubChem CID | 158142560 |
| Molecular Formula | C161H271N35O2S4 |
| Molecular Weight | 2857.45 g/mol |
| Exact Mass | 2855.11 |
| IUPAC Name | N-benzyl-2-methylpropan-2-amine;tris(N-tert-butylaniline);N-tert-butyl-1-methylimidazol-2-amine;N-tert-butyl-1-methylimidazol-4-amine;N-tert-butyl-1,3-oxazol-2-amine;N-tert-butyl-1,3-oxazol-4-amine;N-tert-butylpyrazin-2-amine;N-tert-butylpyridin-2-amine;N-tert-butylpyridin-4-amine;N-tert-butylpyrimidin-2-amine;N-tert-butyl-1,3-thiazol-2-amine;N-tert-butyl-1,3-thiazol-4-amine;ethane;methane;2-methyl-N-(pyridin-2-ylmethyl)propan-2-amine;2-methyl-N-(pyridin-4-ylmethyl)propan-2-amine;2-methyl-N-(1,3-thiazol-4-ylmethyl)propan-2-amine;2-methyl-N-(thiophen-2-ylmethyl)propan-2-amine |
| SMILES | C.CC.CC.CC(C)(C)NCc1ccccc1.CC(C)(C)NCc1ccccn1.CC(C)(C)NCc1cccs1.CC(C)(C)NCc1ccncc1.CC(C)(C)NCc1cscn1.CC(C)(C)Nc1ccccc1.CC(C)(C)Nc1ccccc1.CC(C)(C)Nc1ccccc1.CC(C)(C)Nc1ccccn1.CC(C)(C)Nc1ccncc1.CC(C)(C)Nc1cnccn1.CC(C)(C)Nc1cocn1.CC(C)(C)Nc1cscn1.CC(C)(C)Nc1ncccn1.CC(C)(C)Nc1ncco1.CC(C)(C)Nc1nccs1.Cn1ccnc1NC(C)(C)C.Cn1cnc(NC(C)(C)C)c1 |
| InChI | InChI=1S/C11H17N.2C10H16N2.3C10H15N.2C9H14N2.C9H15NS.2C8H15N3.2C8H13N3.C8H14N2S.2C7H12N2O.2C7H12N2S.2C2H6.CH4/c1-11(2,3)12-9-10-7-5-4-6-8-10;1-10(2,3)12-8-9-4-6-11-7-5-9;1-10(2,3)12-8-9-6-4-5-7-11-9;3*1-10(2,3)11-9-7-5-4-6-8-9;1-9(2,3)11-8-4-6-10-7-5-8;1-9(2,3)11-8-6-4-5-7-10-8;1-9(2,3)10-7-8-5-4-6-11-8;1-8(2,3)10-7-5-11(4)6-9-7;1-8(2,3)10-7-9-5-6-11(7)4;1-8(2,3)11-7-6-9-4-5-10-7;1-8(2,3)11-7-9-5-4-6-10-7;1-8(2,3)10-4-7-5-11-6-9-7;1-7(2,3)9-6-4-10-5-8-6;1-7(2,3)9-6-8-4-5-10-6;1-7(2,3)9-6-4-10-5-8-6;1-7(2,3)9-6-8-4-5-10-6;2*1-2;/h4-8,12H,9H2,1-3H3;2*4-7,12H,8H2,1-3H3;3*4-8,11H,1-3H3;2*4-7H,1-3H3,(H,10,11);4-6,10H,7H2,1-3H3;5-6,10H,1-4H3;5-6H,1-4H3,(H,9,10);4-6H,1-3H3,(H,10,11);4-6H,1-3H3,(H,9,10,11);5-6,10H,4H2,1-3H3;4-5,9H,1-3H3;4-5H,1-3H3,(H,8,9);4-5,9H,1-3H3;4-5H,1-3H3,(H,8,9);2*1-2H3;1H4 |
| InChIKey | FUCSVHOQCFHPOS-UHFFFAOYSA-N |
| XLogP | 42.26 |
| TPSA | 446.03 Ų |
| H-Bond Donors | 18 |
| H-Bond Acceptors | 41 |
| Rotatable Bonds | 23 |
| Heavy Atoms | 202 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2857.45 |
| LogP ≤ 5 | 42.26 |
| H-Bond Donors ≤ 5 | 18 |
| H-Bond Acceptors ≤ 10 | 41 |